A Heart Medicine Was Just Recalled For Containing A Likely Carcinogen
If you take a medicine called Irbesartan, used to treat high blood pressure and hypertension, you'll want to check the label. The FDA announced a voluntary recall of the drug due to trace amounts of the NDEA (N-nitrosodiethylamine) on behalf of Sciegen Pharmaceuticals.
The substance occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and it has been classified as a probable human carcinogen by the International Agency for Research on Cancer.
Twenty-two batches of the drug, with distribution dates between January 2016 and December 2017, were recalled. The bottles affected are labeled "Westminster Pharmaceuticals" or "GSMS Incorporated," and are 30- or 90-count bottles of 75mg, 150mg, or 300mg tablets. The FDA has full details of the bottles affected, including the lot number, on its website.
If you do have one of the affected bottles, contact your doctor before you stop taking the medicine, the announcement says. "The risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any alternative treatment."
('You Might Also Like',)
